Calcium Regulation of Hemorrhagic Fever Virus Budding: Mechanistic Implications for Host-Oriented Therapeutic Intervention

PLoS Pathogens

Volumn 11, Issue 10, 2015, Pages

  Han, Ziying ^a   Madara, Jonathan J ^a   Herbert, Andrew ^b   Prugar, Laura I ^b   Ruthel, Gordon ^a   Lu, Jianhong ^a,d   Liu, Yuliang ^a,e   Liu, Wenbo ^a,f   Liu, Xiaohong ^a   Wrobel, Jay E ^c   Reitz, Allen B ^c   Dye, John M ^b   Harty, Ronald N ^a   Freedman, Bruce D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c Fox Chase Chemical Diversity Center Inc   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e National Veterinary Diagnostic Center (NVDC)   (China)

^f YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; FATTY ACID BINDING PROTEIN; PROTEIN VP40; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STROMAL INTERACTION MOLECULE 1; CALCIUM CHANNEL; MATRIX PROTEIN; ORAI1 PROTEIN, HUMAN; VP40 PROTEIN, VIRUS;

ARENAVIRUS; ARGENTINE HEMORRHAGIC FEVER; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; FILOVIRUS; HUMAN; HUMAN CELL; LASSA VIRUS INFECTION; MARBURG HEMORRHAGIC FEVER; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS LIKE AGENT; VIRUS RELEASE; VIRUS TRANSMISSION; WESTERN BLOTTING; ANIMAL; FILOVIRIDAE; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; PHYSIOLOGY; VERO CELL LINE; VIRION;

ANIMALS; ARENAVIRUS; CALCIUM; CALCIUM CHANNELS; FILOVIRIDAE; HEK293 CELLS; HELA CELLS; HUMANS; ORAI1 PROTEIN; VERO CELLS; VIRAL MATRIX PROTEINS; VIRION; VIRUS RELEASE;

EID: 84946054008     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005220     Document Type: Article

References (70)

1. Chen BJ, Lamb RA, Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology. 2008;372(2):221–32. 18063004
2. Hartlieb B, Weissenhorn W, Filovirus assembly and budding. Virology. 2006;344(1):64–70. 16364737
3. Harty RN, No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res. 2009;81(3):189–97. doi: 10.1016/j.antiviral.2008.12.003 19114059
4. Jasenosky LD, Kawaoka Y, Filovirus budding. Virus research. 2004;106(2):181–8. 15567496
5. Liu Y, Harty RN, Viral and host proteins that modulate filovirus budding. Future Virol. 2010;5(4):481–91. 20730024
6. Urata S, de la Torre JC, Arenavirus budding. Advances in virology. 2011;2011:180326. doi: 10.1155/2011/180326 22312335
7. Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, et al. Ebola virus VP40 late domains are not essential for viral replication in cell culture. Journal of Virology. 2005;79(16):10300–7. 16051823
8. Feldmann H, Klenk HD, Baron S, Filoviruses. In: Medical Microbiology. 4th ed. Galveston (TX)1996.
9. Feldmann H, Klenk HD, Marburg and Ebola viruses. Advances in virus research. 1996;47:1–52. 8895830
10. Grant A, Seregin A, Huang C, Kolokoltsova O, Brasier A, Peters C, et al. Junin virus pathogenesis and virus replication. Viruses. 2012;4(10):2317–39. doi: 10.3390/v4102317 23202466
11. Yun NE, Walker DH, Pathogenesis of Lassa fever. Viruses. 2012;4(10):2031–48. doi: 10.3390/v4102031 23202452
12. Lingappa UF, Wu X, Macieik A, Yu SF, Atuegbu A, Corpuz M, et al. Host-rabies virus protein-protein interactions as druggable antiviral targets. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(10):E861–8. doi: 10.1073/pnas.1210198110 23404707
13. Adamson CS, Freed EO, Novel approaches to inhibiting HIV-1 replication. Antiviral research. 2010;85(1):119–41. doi: 10.1016/j.antiviral.2009.09.009 19782103
14. Aman MJ, Kinch MS, Warfield K, Warren T, Yunus A, Enterlein S, et al. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral research. 2009;83(3):245–51. doi: 10.1016/j.antiviral.2009.06.001 19523489
15. Andrei G, De Clercq E, Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral research. 1993;22(1):45–75. 8250543
16. Connor JH, McKenzie MO, Parks GD, Lyles DS, Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses. Virology. 2007;362(1):109–19. 17258257
17. Garcia M, Cooper A, Shi W, Bornmann W, Carrion R, Kalman D, et al. Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase. Science translational medicine. 2012;4(123):123ra24. doi: 10.1126/scitranslmed.3003500 22378924
18. Kinch MS, Yunus AS, Lear C, Mao H, Chen H, Fesseha Z, et al. FGI-104: a broad-spectrum small molecule inhibitor of viral infection. American journal of translational research. 2009;1(1):87–98. 19966942
19. Kolokoltsov AA, Adhikary S, Garver J, Johnson L, Davey RA, Vela EM, Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin. Archives of virology. 2012;157(1):121–7. doi: 10.1007/s00705-011-1115-8 21947546
20. Perez M, Craven RC, de la Torre JC, The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(22):12978–83. 14563923
21. Tavassoli A, Lu Q, Gam J, Pan H, Benkovic SJ, Cohen SN, Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS chemical biology. 2008;3(12):757–64. doi: 10.1021/cb800193n 19053244
22. Urata S, Ngo N, de la Torre JC, The PI3K/Akt Pathway Contributes To Arenavirus Budding. J Virol. 2012;86(8):4578–85. doi: 10.1128/JVI.06604-11 22345463
23. Warren TK, Warfield KL, Wells J, Enterlein S, Smith M, Ruthel G, et al. Antiviral activity of a small-molecule inhibitor of filovirus infection. Antimicrobial agents and chemotherapy. 2010;54(5):2152–9. doi: 10.1128/AAC.01315-09 20211898
24. Stathopulos PB, Li GY, Plevin MJ, Ames JB, Ikura M, Stored Ca2+ depletion-induced oligomerization of stromal interaction molecule 1 (STIM1) via the EF-SAM region: An initiation mechanism for capacitive Ca2+ entry. JBiolChem. 2006;281(47):35855–62.
25. Hogan PG, Lewis RS, Rao A, Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol. 2010;28:491–533. doi: 10.1146/annurev.immunol.021908.132550 20307213
26. Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, et al. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science. 2006;312(5777):1220–3. 16645049
27. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006;441(7090):179–85. 16582901
28. Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, et al. Genome-wide RNAi screen of Ca2+ influx identifies genes that regulate Ca2+ release-activated Ca2+ channel activity. ProcNatlAcadSciUSA. 2006;103(24):9357–62.
29. Rao A, Signaling to gene expression: calcium, calcineurin and NFAT. Nat Immunol. 2009;10(1):3–5. doi: 10.1038/ni0109-3 19088731
30. Babich A, Burkhardt JK, Coordinate control of cytoskeletal remodeling and calcium mobilization during T-cell activation. Immunological reviews. 2013;256(1):80–94. doi: 10.1111/imr.12123 24117814
31. Freedman BD, Mechanisms of calcium signaling and function in lymphocytes. Critical Reviews in Immunology. 2006;26(2):97–111. 16700648
32. Han Z, Harty RN, Influence of calcium/calmodulin on budding of Ebola VLPs: implications for the involvement of the Ras/Raf/MEK/ERK pathway. Virus Genes. 2007;35(3):511–20. 17570046
33. Su S, Phua SC, DeRose R, Chiba S, Narita K, Kalugin PK, et al. Genetically encoded calcium indicator illuminates calcium dynamics in primary cilia. Nature methods. 2013;10:1105–07. doi: 10.1038/nmeth.2647 24056873
34. Hou X, Pedi L, Diver MM, Long SB, Crystal structure of the calcium release-activated calcium channel Orai. Science. 2012;338(6112):1308–13. doi: 10.1126/science.1228757 23180775
35. Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE, Jr.et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. CurrBiol. 2005;15(13):1235–41.
36. Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function. JCell Biol. 2005;169(3):435–45.
37. Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, et al. STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature. 2005;437(7060):902–5. 16208375
38. Prakriya M, Lewis RS, Potentiation and inhibition of Ca2+ release-activated Ca2+ channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP(3) receptors. JPhysiol. 2001;536(Pt 1):3–19.
39. Ng SW, Di CJ, Singaravelu K, Parekh AB, Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels. JBiolChem. 2008;283(46):31348–55.
40. Chen G, Panicker S, Lau KY, Apparsundaram S, Patel VA, Chen SL, et al. Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions. Molecular immunology. 2013;54(3–4):355–67. 23357789
41. Cuevas CD, Lavanya M, Wang E, Ross SR, Junin virus infects mouse cells and induces innate immune responses. Journal of virology. 2011;85(21):11058–68. doi: 10.1128/JVI.05304-11 21880772
42. Lu J, Han Z, Liu Y, Liu W, Lee MS, Olson MA, et al. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol. 2014;88(9):4736–43. doi: 10.1128/JVI.03757-13 24522922
43. Ehrlich LS, Carter CA, HIV Assembly and Budding: Ca(2+) Signaling and Non-ESCRT Proteins Set the Stage. Mol Biol Int. 2012;2012:851670. doi: 10.1155/2012/851670 22761998
44. Ehrlich LS, Medina GN, Carter CA, ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca2+ signaling cascade. Journal of molecular biology. 2011;413(2):347–58. 21875593
45. Wang J, Peng Q, Lin Q, Childress C, Carey D, Yang W, Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition. J Biol Chem. 2010;285(16):12279–88. doi: 10.1074/jbc.M109.086405 20172859
46. Bissig C, Lenoir M, Velluz M-CC, Kufareva I, Abagyan R, Overduin M, et al. Viral infection controlled by a calcium-dependent lipid-binding module in ALIX. Developmental cell. 2013;25(4):364–73. doi: 10.1016/j.devcel.2013.04.003 23664863
47. Maki M, Suzuki H, Shibata H, Structure and function of ALG-2, a penta-EF-hand calcium-dependent adaptor protein. Sci China Life Sci. 2011;54(8):770–9. doi: 10.1007/s11427-011-4204-8 21786200
48. Scheffer LL, Sreetama SC, Sharma N, Medikayala S, Brown KJ, Defour A, et al. Mechanism of Ca2+-triggered ESCRT assembly and regulation of cell membrane repair. Nat Commun. 2014;5:5646. doi: 10.1038/ncomms6646 25534348
49. Hyser JM, Utama B, Crawford SE, Broughman JR, Estes MK, Activation of the endoplasmic reticulum calcium sensor STIM1 and store-operated calcium entry by rotavirus requires NSP4 viroporin activity. Journal of virology. 2013;87(24):13579–88. doi: 10.1128/JVI.02629-13 24109210
50. Siddharthan V, Wang H, Davies CJ, Hall JO, Morrey JD, Inhibition of west nile virus by calbindin-D28k. PLoS One. 2014;9(9):e106535. doi: 10.1371/journal.pone.0106535 25180779
51. Scherbik SV, Brinton MA, Virus-induced Ca2+ influx extends survival of west nile virus-infected cells. J Virol. 2010;84(17):8721–31. doi: 10.1128/JVI.00144-10 20538858
52. de Jong AS, Visch HJ, de Mattia F, van Dommelen MM, Swarts HG, Luyten T, et al. The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein trafficking through the Golgi. J Biol Chem. 2006;281(20):14144–50. 16540472
53. van Kuppeveld FJ, Hoenderop JG, Smeets RL, Willems PH, Dijkman HB, Galama JM, et al. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J. 1997;16(12):3519–32. 9218794
54. Yang B, Bouchard MJ, The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. J Virol. 2012;86(1):313–27. doi: 10.1128/JVI.06442-11 22031934
55. Dellis O, Arbabian A, Papp B, Rowe M, Joab I, Chomienne C, Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells. J Biol Chem. 2011;286(21):18583–92. doi: 10.1074/jbc.M111.222257 21454636
56. Dellis O, Arbabian A, Brouland JP, Kovacs T, Rowe M, Chomienne C, et al. Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. Molecular cancer. 2009;8:59. doi: 10.1186/1476-4598-8-59 19650915
57. Lavanya M, Cuevas CD, Thomas M, Cherry S, Ross SR, siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target. Science translational medicine. 2013;5(204).
58. Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. MolPharmacol. 1994;45(6):1227–34.
59. Verheugen JA, Korn H, A charybdotoxin-insensitive conductance in human T lymphocytes: T cell membrane potential is set by distinct K+ channels. JPhysiol (Lond). 1997;503 (Pt 2):317–31.
60. Freedman BD, Price MA, Deutsch CJ, Evidence for voltage modulation of IL-2 production in mitogen- stimulated human peripheral blood lymphocytes. JImmunol. 1992;149(12):3784–94.
61. Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, et al. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. JImmunol. 1997;158(11):5120–8.
62. Hess SD, Oortgiesen M, Cahalan MD, Calcium oscillations in human T and natural killer cells depend upon membrane potential and calcium influx. JImmunol. 1993;150:2620–33.
63. Han Z, Lu J, Liu Y, Davis B, Lee MS, Olson MA, et al. Small-Molecule Probes Targeting the Viral PPxY-Host Nedd4 Interface Block Egress of a Broad Range of RNA Viruses. J Virol. 2014;88(13):7294–306. doi: 10.1128/JVI.00591-14 24741084
64. Fuchs S, Rensing-Ehl A, Speckmann C, Bengsch B, Schmitt-Graeff A, Bondzio I, et al. Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. JImmunol. 2012;188(3):1523–33.
65. Oh-Hora M, Yamashita M, Hogan PG, Sharma S, Lamperti E, Chung W, et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol. 2008;9(4):432–43. doi: 10.1038/ni1574 18327260
66. Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN, Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol. 2003;77(3):1812–9. 12525615
67. Lu J, Qu Y, Liu Y, Jambusaria R, Han Z, Ruthel G, et al. Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress. J Virol. 2013;87(13):7777–80. doi: 10.1128/JVI.00470-13 23637409
68. Moe JB, Lambert RD, Lupton HW, Plaque assay for Ebola virus. J Clin Microbiol. 1981;13(4):791–3. 7014628
69. Tomori O, Johnson KM, Kiley MP, Elliott LH, Standardization of a plaque assay for Lassa virus. Journal of medical virology. 1987;22(1):77–89. 3585290
70. Bushar G, Sagripanti JL, Method for improving accuracy of virus titration: standardization of plaque assay for Junin virus. Journal of virological methods. 1990;30(1):99–107. 1707890